Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

The treatment is safe and shows promise for metastatic breast cancer.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

Selaginella doederleinii extract shows potential for cervical cancer treatment but needs more research.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Entospletinib effectively prevents eye and skin GVHD in mice.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

New cancer treatments aim to reduce side effects and improve effectiveness.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Orlistat might block the body's ability to absorb thyroid medication.